Prevalence of extended-spectrum cephalosporin-, carbapenem-, and fluoroquinolone-resistant members of the family Enterobacteriaceae isolated from the feces of horses and hospital surfaces at two equine specialty hospitals.
Abstract: To estimate the prevalence of extended-spectrum cephalosporin-, carbapenem-, and fluoroquinolone-resistant bacteria of the family Enterobacteriaceae in the feces of hospitalized horses and on hospital surfaces. Methods: Fecal and environmental samples were collected from The Ohio State University Galbreath Equine Center (OSUGEC) and a private referral equine hospital in Kentucky (KYEH). Feces were sampled within 24 hours after hospital admission and after 48 hours and 3 to 7 days of hospitalization. Methods: Fecal and environmental samples were enriched, and then selective media were inoculated to support growth of Enterobacteriaceae bacteria that expressed resistance phenotypes to extended-spectrum cephalosporins, carbapenems, and fluoroquinolones. Results: 358 fecal samples were obtained from 143 horses. More samples yielded growth of Enterobacteriaceae bacteria that expressed resistance phenotypes (AmpC β-lactamase, OR = 4.2; extended-spectrum beta-lactamase, OR = 3.2; and fluoroquinolone resistance, OR = 4.0) after 48 hours of hospitalization, versus within 24 hours of hospital admission. Horses hospitalized at KYEH were at greater odds of having fluoroquinolone-resistant bacteria (OR = 2.2). At OSUGEC, 82%, 64%, 0%, and 55% of 164 surfaces had Enterobacteriaceae bacteria with AmpC β-lactamase phenotype, extended-spectrum beta-lactamase phenotype, resistance to carbapenem, and resistance to fluoroquinolones, respectively; prevalences at KYEH were similarly distributed (52%, 32%, 1%, and 35% of 315 surfaces). Conclusions: Results indicated that antimicrobial-resistant Enterobacteriaceae may be isolated from the feces of hospitalized horses and from the hospital environment. Hospitalization may lead to increased fecal carriage of clinically important antimicrobial-resistance genes.
Publication Date: 2021-03-24 PubMed ID: 33754819DOI: 10.2460/javma.258.7.758Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study investigates the prevalence of antibiotic-resistant bacteria within the Enterobacteriaceae family, particularly those resistant to extended-spectrum cephalosporins, carbapenems, and fluoroquinolones, in the feces of hospitalised horses and on hospital surfaces. The research establishes that horses under hospitalisation may contribute to the spread of antibiotic-resistant bacteria.
Methods
- Fecal and environmental samples were collected from two hospitals – The Ohio State University Galbreath Equine Center (OSUGEC) and a private referral equine hospital in Kentucky (KYEH).
- Feces samples were processed within 24 hours of admission, followed by a test after 48 hours and between 3-7 days of hospitalisation.
- The samples underwent an enrichment process before being inoculated on selective media designed to promote the growth of Enterobacteriaceae bacteria exhibiting resistance to extended-spectrum cephalosporins, carbapenems, and fluoroquinolones.
Results
- A total of 358 fecal samples from 143 horses were evaluated.
- There was a noticeable increase in the growth of resistant bacteria – particularly, AmpC β-lactamase, extended-spectrum beta-lactamase, and fluoroquinolone-resistant Enterobacteriaceae, after the horses were hospitalized for 48 hours as compared to the samples collected within the first 24 hours.
- Horses in the Kentucky hospital were found to be more likely to host fluoroquinolone-resistant bacteria.
- In the Ohio hospital, between 68% and 82% of the sampled surfaces harbored antibiotic-resistant Enterobacteriaceae. The bacteria types were distributed similarly in the Kentucky hospital, albeit in generally lower proportions (between 32%-52% of surfaces).
Conclusions
- The findings indicate the presence of antimicrobial-resistant bacteria in both the feces of hospitalized horses and within the hospital environment.
- The study also suggests that the process of hospitalization might lead to an increased presence of clinically important antimicrobial-resistance genes in the feces of horses.
Cite This Article
APA
Adams RJ, Mollenkopf DF, Mathys DA, Whittle A, Ballash GA, Mudge M, Daniels JB, Barr B, Wittum TE.
(2021).
Prevalence of extended-spectrum cephalosporin-, carbapenem-, and fluoroquinolone-resistant members of the family Enterobacteriaceae isolated from the feces of horses and hospital surfaces at two equine specialty hospitals.
J Am Vet Med Assoc, 258(7), 758-766.
https://doi.org/10.2460/javma.258.7.758 Publication
Researcher Affiliations
MeSH Terms
- Animals
- Anti-Bacterial Agents / pharmacology
- Carbapenems
- Cephalosporins
- Enterobacteriaceae
- Feces
- Fluoroquinolones / pharmacology
- Horses
- Hospitals
- Ohio
- Prevalence
Grant Funding
- T35 OD010977 / NIH HHS
Citations
This article has been cited 1 times.- Theelen MJP, Luiken REC, Wagenaar JA, Sloet van Oldruitenborgh-Oosterbaan MM, Rossen JWA, Schaafstra FJWC, van Doorn DA, Zomer AL. Longitudinal study of the short- and long-term effects of hospitalisation and oral trimethoprim-sulfadiazine administration on the equine faecal microbiome and resistome.. Microbiome 2023 Feb 27;11(1):33.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists